Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016) [Phase 4]

View source ↗

Summary

Phase 4 study assessing safety, tolerability, and immunogenicity of the hexavalent vaccine Vaxelis in children previously vaccinated with Vaxelis or Hexyon; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Pertussis
• Poliomyelitis
• Tetanus
• Viral Hepatitis

Drugs mentioned

• Vaxelis (DTaP5-HBV-IPV-Hib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Vaccines, Combined, Hexavalent Vaccine | Phase 4 | Status: COMPLETED | Results posted: 2023-09-06